B Group, Inc.
CIK 0002043476 · DALLAS, TX · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source ↗
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$213.0M
2026 Q2
Positions
19
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
79.5%
Est. Net Flow (Q)
—
2026 Q2
Top Holdings
46090E953PUT
INVESCO QQQ TR
17.3%
ADMA
ADMA BIOLOGICS INC
12.8%
PALI
PALISADE BIO INC
11.2%
NRXP
NRX PHARMACEUTICALS INC
7.9%
FTH
FAETH THERAPEUTICS INC
7.2%
TSHA
TAYSHA GENE THERAPIES INC
5.8%
PRAX
PRAXIS PRECISION MEDICINES I
5.2%
CLLS
CELLECTIS S A
4.6%
New / Increased
No prior quarter data
Reduced / Exited
No prior quarter data
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.